Results 251 to 260 of about 276,656 (346)

Usefulness of preoperative peripheral blood GPC3‐positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study

open access: yesHepatology Research, EarlyView.
Peripheral blood glypican‐3 (GPC3)‐positive circulating tumor cells (CTCs) are a risk factor for microscopic portal vein invasion and a prognostic factor in Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC). Combining the number of GPC3‐positive CTCs with the up‐to‐7 criteria enables highly accurate subclassification of BCLC ...
Yosuke Namba   +15 more
wiley   +1 more source

HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis

open access: bronze, 1995
Christian Oesterreicher   +6 more
openalex   +1 more source

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases

open access: yesHepatology Research, EarlyView.
Hepatocellular carcinoma (HCC) in the hepatitis C virus (HCV)‐sustained virologic response (SVR) group was associated with alcohol consumption and metabolic diseases and showed significantly lower rates of ARID2 alterations and AXIN1 alterations compared to the HCV‐non‐SVR group, with a mutational profile resembling that of the steatotic liver disease ...
Fukiko Kawai‐Kitahata   +21 more
wiley   +1 more source

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs

open access: yesHepatology Research, EarlyView.
The risk of HCC persists long after NUC initiation. In noncirrhotic patients, the risk remains stable more than 10 years after NUC treatment initiation. ABSTRACT Background and Aim Nucleos(t)ide analogs (NUCs) are used in the treatment of chronic hepatitis B (CHB).
Kazuhiro Murai   +36 more
wiley   +1 more source

Causes of death in people living with HIV from a North London cohort between 2006 and 2023: A descriptive analysis

open access: yesHIV Medicine, EarlyView.
Abstract Background The provision of highly active anti‐retroviral therapy has improved outcomes for people with HIV, worldwide. There are few data on trends and changes in the cause of death among people with HIV in the United Kingdom since its advent.
Linda Cheyenne Vaccari   +5 more
wiley   +1 more source

Adjusted Versus Total Body Weight Dosing for Intravenous Heparin Infusions and Target Attainment in Obese Patients. [PDF]

open access: yesHosp Pharm
Nguyen K   +6 more
europepmc   +1 more source

A case of primary biliary cirrhosis complicated with hepatocellular carcinoma showing negative results for HCV, HBV and HGV markers.

open access: bronze, 1997
M. Ogura   +16 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy